运动干预机制以及个性化运动处方对代谢相关脂肪性肝病的影响

果可欣; 桂沛君; 谢瑛

doi:10.12449/JCH250827

运动干预机制以及个性化运动处方对代谢相关脂肪性肝病的影响

DOI: 10.12449/JCH250827

果可欣^{1, 2},
桂沛君¹,
谢瑛^1, , ,

1.
首都医科大学附属北京友谊医院康复医学科，北京 100050
2.
天津体育学院运动健康学院，天津 301617

基金项目:

首都卫生科研发展专项 (First Launch, 2024-2-2027)

利益冲突声明：本文不存在任何利益冲突。

作者贡献声明：果可欣负责查阅文献，撰写论文；桂沛君对论文进行审阅与修改；谢瑛对文章的知识性内容作批评性审阅并最后定稿。

详细信息

通信作者:
谢瑛， xieying@ccmu.edu.cn （ORCID： 0000-0002-6619-3939）

计量
- 文章访问数: 282
- HTML全文浏览量: 108
- PDF下载量: 29
- 被引次数: 0
出版历程
- 收稿日期: 2024-12-31
- 录用日期: 2025-03-04
- 出版日期: 2025-08-25

The effect of the mechanism of exercise intervention and individualized exercise prescription on metabolic dysfunction-associated fatty liver disease

Kexin GUO^{1, 2},
Peijun GUI¹,
Ying XIE^{1
, ,
,}

1.
Department of Rehabilitation Medicine，Beijing Friendship Hospital，Capital Medical University，Beijing 100050，China
2.
School of Sports and Health，Tianjin Institute of Physical Education，Tianjin 301617，China

Research funding:

Capital Health Research and Development Special Project (First Launch, 2024-2-2027)

More Information

Corresponding author: XIE Ying， xieying@ccmu.edu.cn （ORCID： 0000-0002-6619-3939）

摘要

摘要: 生活方式的改变比如增加运动，是影响代谢相关脂肪性肝病（MAFLD）患者健康和生活质量的关键因素。运动能够有效改善这类患者的身体健康，是治疗MAFLD的基石。然而，不同类型、强度、时间和频率的运动对MAFLD产生各不相同的影响。本研究综述了不同运动处方对MAFLD患者的作用和影响，有助于医护人员制定个性化的运动方案，鼓励患者积极参与运动锻炼，从而提供有效的预防和治疗策略。
- 代谢相关脂肪性肝病 /
- 生活方式 /
- 运动
Abstract: Changes in lifestyle， such as increasing exercise， are key factors affecting the health and quality of life in patients with metabolic dysfunction-associated fatty liver disease （MAFLD）. Exercise can effectively improve the physical health of these patients and is the cornerstone of the treatment of MAFLD. However， different types， intensities， durations， and frequencies of exercise have a varying degree of influence on MAFLD. This article summarizes the effect and influence of different exercise prescriptions on these patients， which helps the medical staff to develop individualized exercise regimens and encourage them to actively participate in exercise， thereby providing effective prevention and treatment strategies.
- Metabolic Dysfunction-Associated Fatty Liver Disease /
- Life Style /
- Motion

HTML全文

参考文献(49)

[1]	MACHADO MV. Aerobic exercise in the management of metabolic dysfunction associated fatty liver disease[J]. Diabetes Metab Syndr Obes, 2021, 14: 3627- 3645. DOI: 10.2147/DMSO.S304357.
[2]	MITRA S, DE A, CHOWDHURY A. Epidemiology of non-alcoholic and alcoholic fatty liver diseases[J]. Transl Gastroenterol Hepatol, 2020, 5: 16. DOI: 10.21037/tgh.2019.09.08.
[3]	ZHOU JH, ZHOU F, WANG WX, et al. Epidemiological features of NAFLD from 1999 to 2018 in China[J]. Hepatology, 2020, 71( 5): 1851- 1864. DOI: 10.1002/hep.31150.
[4]	ZHOU F, ZHOU JH, WANG WX, et al. Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: A systematic review and meta-analysis[J]. Hepatology, 2019, 70( 4): 1119- 1133. DOI: 10.1002/hep.30702.
[5]	DUAN MX, CHEN XL, CHANG WY, et al. Advances in the multi-omics research on nonalcoholic fatty liver disease[J]. J Clin Hepatol, 2024, 40( 6): 1240- 1247. DOI: 10.12449/JCH240626. 段明秀, 陈新利, 常伟宇, 等. 非酒精性脂肪性肝病多组学研究现状[J]. 临床肝胆病杂志, 2024, 40( 6): 1240- 1247. DOI: 10.12449/JCH240626.
[6]	LA FUENTE FP, QUEZADA L, SEPÚLVEDA C, et al. Exercise regulates lipid droplet dynamics in normal and fatty liver[J]. Biochim Biophys Acta Mol Cell Biol Lipids, 2019, 1864( 12): 158519. DOI: 10.1016/j.bbalip.2019.158519.
[7]	LINDEN MA, SHELDON RD, MEERS GM, et al. Aerobic exercise training in the treatment of non-alcoholic fatty liver disease related fibrosis[J]. J Physiol, 2016, 594( 18): 5271- 5284. DOI: 10.1113/JP272235.
[8]	TUNG BT, RODRIGUEZ-BIES E, THANH HN, et al. Organ and tissue-dependent effect of resveratrol and exercise on antioxidant defenses of old mice[J]. Aging Clin Exp Res, 2015, 27( 6): 775- 783. DOI: 10.1007/s40520-015-0366-8.
[9]	XIAO ZL, LU CX, ZHOU DN, et al. Role of lipophagy in the prevention and treatment of nonalcoholic fatty liver disease[J]. J Clin Hepatol, 2024, 40( 7): 1450- 1458. DOI: 10.12449/JCH240725. 肖智利, 卢晨霞, 周丹妮, 等. 脂肪自噬在非酒精性脂肪性肝病防治中的作用[J]. 临床肝胆病杂志, 2024, 40( 7): 1450- 1458. DOI: 10.12449/JCH240725.
[10]	YANG BQ, YIN JY, WANG Q. The mechanism of action of mitochondrial dysfunction in the development of non-alcoholic fatty liver disease[J]. J Clin Hepatol, 2024, 40( 1): 147- 150. DOI: 10.12449/JCH240124. 杨冰清, 尹静亚, 王琦. 肝线粒体功能障碍在非酒精性脂肪性肝病发病中的作用机制[J]. 临床肝胆病杂志, 2024, 40( 1): 147- 150. DOI: 10.12449/JCH240124.
[11]	SŁOMKO J, ZALEWSKA M, NIEMIRO W, et al. Evidence-based aerobic exercise training in metabolic-associated fatty liver disease: Systematic review with meta-analysis[J]. J Clin Med, 2021, 10( 8): 1659. DOI: 10.3390/jcm10081659.
[12]	SABAG A, BARR L, ARMOUR M, et al. The effect of high-intensity interval training vs moderate-intensity continuous training on liver fat: A systematic review and meta-analysis[J]. J Clin Endocrinol Metab, 2022, 107( 3): 862- 881. DOI: 10.1210/clinem/dgab795.
[13]	MOHAMMAD RAHIMI GR, ATTARZADEH HOSSEINI SR. Effect of aerobic exercise alone or in conjunction with diet on liver function, insulin resistance and lipids in non-alcoholic fatty liver disease[J]. Biol Res Nurs, 2022, 24( 2): 259- 276. DOI: 10.1177/10998004211068026.
[14]	NAM H, YOO JJ, CHO Y, et al. Effect of exercise-based interventions in nonalcoholic fatty liver disease: A systematic review with meta-analysis[J]. Dig Liver Dis, 2023, 55( 9): 1178- 1186. DOI: 10.1016/j.dld.2022.12.013.
[15]	MENDEZ-SANCHEZ N, ARRESE M, GADANO A, et al. The Latin American Association for the Study of the Liver(ALEH) position statement on the redefinition of fatty liver disease[J]. Lancet Gastroenterol Hepatol, 2021, 6( 1): 65- 72. DOI: 10.1016/S2468-1253(20)30340-X.
[16]	ORCI LA, GARIANI K, OLDANI G, et al. Exercise-based interventions for nonalcoholic fatty liver disease: A meta-analysis and meta-regression[J]. Clin Gastroenterol Hepatol, 2016, 14( 10): 1398- 1411. DOI: 10.1016/j.cgh.2016.04.036.
[17]	CHARATCHAROENWITTHAYA P, KULJIRATITIKAL K, AKSORNCHANYA O, et al. Moderate-intensity aerobic vs resistance exercise and dietary modification in patients with nonalcoholic fatty liver disease: A randomized clinical trial[J]. Clin Transl Gastroenterol, 2021, 12( 3): e00316. DOI: 10.14309/ctg.0000000000000316.
[18]	SON WM, PARK JJ. Resistance band exercise training prevents the progression of metabolic syndrome in obese postmenopausal women[J]. J Sports Sci Med, 2021, 20( 2): 291- 299. DOI: 10.52082/jssm.2021.291.
[19]	KIM HJ, LEE HJ, SO B, et al. Effect of aerobic training and resistance training on circulating irisin level and their association with change of body composition in overweight/obese adults: A pilot study[J]. Physiol Res, 2016, 65( 2): 271- 279. DOI: 10.33549/physiolres.932997.
[20]	PARK Y, SINN DH, KIM K, et al. Associations of physical activity domains and muscle strength exercise with non-alcoholic fatty liver disease: A nation-wide cohort study[J]. Sci Rep, 2023, 13( 1): 4724. DOI: 10.1038/s41598-023-31686-6.
[21]	MEDEIROS DG, FERREIRA LF, LAMP JDS, et al. The impact of resistance training in patients diagnosed with metabolic dysfunction-associated steatotic liver disease: A systematic review[J]. Eur J Gastroenterol Hepatol, 2025, 37( 2): 129- 136. DOI: 10.1097/MEG.0000000000002887.
[22]	KEATING SE, SABAG A, HALLSWORTH K, et al. Exercise in the management of metabolic-associated fatty liver disease(MAFLD) in adults: A position statement from exercise and sport science Australia[J]. Sports Med, 2023, 53( 12): 2347- 2371. DOI: 10.1007/s40279-023-01918-w.
[23]	TEO SYM, KANALEY JA, GUELFI KJ, et al. Exercise timing in type 2 diabetes mellitus: A systematic review[J]. Med Sci Sports Exerc, 2018, 50( 12): 2387- 2397. DOI: 10.1249/MSS.0000000000001732.
[24]	ALLISON MK, BAGLOLE JH, MARTIN BJ, et al. Brief intense stair climbing improves cardiorespiratory fitness[J]. Med Sci Sports Exerc, 2017, 49( 2): 298- 307. DOI: 10.1249/MSS.0000000000001188.
[25]	HASHIDA R, MATSUSE H, KAWAGUCHI T, et al. Effects of a low-intensity resistance exercise program on serum miR-630, miR-5703, and fractalkine/CX3CL1 expressions in subjects with no exercise habits: A preliminary study[J]. Hepatol Res, 2021, 51( 7): 823- 833. DOI: 10.1111/hepr.13670.
[26]	ZHANG Y, WEI QM, GENG X, et al. Long-term aerobic exercise enhances hepatoprotection in MAFLD by modulating exosomal miR-324 via ROCK1[J]. Metabolites, 2024, 14( 12): 692. DOI: 10.3390/metabo14120692.
[27]	O’GORMAN P, NAIMIMOHASSES S, MONAGHAN A, et al. Improvement in histological endpoints of MAFLD following a 12-week aerobic exercise intervention[J]. Aliment Pharmacol Ther, 2020, 52( 8): 1387- 1398. DOI: 10.1111/apt.15989.
[28]	MASCARÓ CM, BOUZAS C, MONTEMAYOR S, et al. Effect of a six-month lifestyle intervention on the physical activity and fitness status of adults with NAFLD and metabolic syndrome[J]. Nutrients, 2022, 14( 9): 1813. DOI: 10.3390/nu14091813.
[29]	SABAG A, LITTLE JP, JOHNSON NA. Low-volume high-intensity interval training for cardiometabolic health[J]. J Physiol, 2022, 600( 5): 1013- 1026. DOI: 10.1113/JP281210.
[30]	JOO JH, KIM HJ, PARK EC, et al. Association between sitting time and non-alcoholic fatty live disease in South Korean population: A cross-sectional study[J]. Lipids Health Dis, 2020, 19( 1): 212. DOI: 10.1186/s12944-020-01385-6.
[31]	KEATING SE, CROCI I, WALLEN MP, et al. High-intensity interval training for the management of nonalcoholic steatohepatitis: Participant experiences and perspectives[J]. J Clin Transl Hepatol, 2023, 11( 5): 1050- 1060. DOI: 10.14218/JCTH.2022.00091S.
[32]	ABDELBASSET WK, TANTAWY SA, KAMEL DM, et al. Effects of high-intensity interval and moderate-intensity continuous aerobic exercise on diabetic obese patients with nonalcoholic fatty liver disease: A comparative randomized controlled trial[J]. Medicine(Baltimore), 2020, 99( 10): e19471. DOI: 10.1097/MD.0000000000019471.
[33]	MOTIANI KK, SAVOLAINEN AM, TOIVANEN J, et al. Effects of short-term sprint interval and moderate-intensity continuous training on liver fat content, lipoprotein profile, and substrate uptake: A randomized trial[J]. J Appl Physiol(1985), 2019, 126( 6): 1756- 1768. DOI: 10.1152/japplphysiol.00900.2018.
[34]	CROCI I, COOMBES JS, BUCHER SANDBAKK S, et al. Non-alcoholic fatty liver disease: Prevalence and all-cause mortality according to sedentary behaviour and cardiorespiratory fitness. The HUNT Study[J]. Prog Cardiovasc Dis, 2019, 62( 2): 127- 134. DOI: 10.1016/j.pcad.2019.01.005.
[35]	RYU S, CHANG Y, JUNG HS, et al. Relationship of sitting time and physical activity with non-alcoholic fatty liver disease[J]. J Hepatol, 2015, 63( 5): 1229- 1237. DOI: 10.1016/j.jhep.2015.07.010.
[36]	WEI HL, QU H, WANG H, et al. Associations between sitting time and non-alcoholic fatty liver diseases in Chinese male workers: A cross-sectional study[J]. BMJ Open, 2016, 6( 9): e011939. DOI: 10.1136/bmjopen-2016-011939.
[37]	CHIN EC, LEUNG CK, YU DJ, et al. Effects of one-year once-weekly high-intensity interval training on body adiposity and liver fat in adults with central obesity: Study protocol for a randomized controlled trial[J]. J Exerc Sci Fit, 2022, 20( 2): 161- 171. DOI: 10.1016/j.jesf.2022.03.003.
[38]	NODA H, HARADA M, YOKOTA K, et al. Individualized health education with sports gym use and dietary advice for overweight and obese persons in a community. Kokuho Health-up model Program in Chikusei-shi(former Kyowa town)[J]. Nihon Koshu Eisei Zasshi, 2006, 53( 10): 749- 761.
[39]	STINE JG, LONG MT, COREY KE, et al. American College of Sports Medicine(ACSM) International Multidisciplinary Roundtable report on physical activity and nonalcoholic fatty liver disease[J]. Hepatol Commun, 2023, 7( 4): e0108. DOI: 10.1097/HC9.0000000000000108.
[40]	WESTON KS, WISLØFF U, COOMBES JS. High-intensity interval training in patients with lifestyle-induced cardiometabolic disease: A systematic review and meta-analysis[J]. Br J Sports Med, 2014, 48( 16): 1227- 1234. DOI: 10.1136/bjsports-2013-092576.
[41]	ABDELBASSET WK, ELSAYED SH, NAMBI G, et al. Effect of moderate-intensity aerobic exercise on hepatic fat content and visceral lipids in hepatic patients with diabesity: A single-blinded randomised controlled trial[J]. Evid Based Complement Alternat Med, 2020, 2020: 1923575. DOI: 10.1155/2020/1923575.
[42]	BERGE J, HJELMESAETH J, HERTEL JK, et al. Effect of aerobic exercise intensity on energy expenditure and weight loss in severe obesity-a randomized controlled trial[J]. Obesity(Silver Spring), 2021, 29( 2): 359- 369. DOI: 10.1002/oby.23078.
[43]	SIMON TG, KIM MN, LUO X, et al. Physical activity compared to adiposity and risk of liver-related mortality: Results from two prospective, nationwide cohorts[J]. J Hepatol, 2020, 72( 6): 1062- 1069. DOI: 10.1016/j.jhep.2019.12.022.
[44]	KENNEALLY S, SIER JH, BERNADETTE MOORE J. Efficacy of dietary and physical activity intervention in non-alcoholic fatty liver disease: A systematic review[J]. BMJ Open Gastroenterol, 2017, 4( 1): e000139. DOI: 10.1136/bmjgast-2017-000139.
[45]	SLENTZ CA, BATEMAN LA, WILLIS LH, et al. Effects of aerobic vs. resistance training on visceral and liver fat stores, liver enzymes, and insulin resistance by HOMA in overweight adults from STRRIDE AT/RT[J]. Am J Physiol Endocrinol Metab, 2011, 301( 5): E1033- E1039. DOI: 10.1152/ajpendo.00291.2011.
[46]	HEJAZI K, HACKETT D. Effect of exercise on liver function and insulin resistance markers in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials[J]. J Clin Med, 2023, 12( 8): 3011. DOI: 10.3390/jcm12083011.
[47]	XIONG YZ, PENG QW, CAO CM, et al. Effect of different exercise methods on non-alcoholic fatty liver disease: A meta-analysis and meta-regression[J]. Int J Environ Res Public Health, 2021, 18( 6): 3242. DOI: 10.3390/ijerph18063242.
[48]	KONG JN, ZHANG BB, SHI JP. An excerpt of clinical practice guideline of prevention and treatment of metabolic dysfunction-associated(non-alcoholic) fatty liver disease(2024 edition)[J]. J Clin Hepatol, 2024, 40( 9): 1767- 1770. DOI: 10.12449/JCH240908. 孔嘉宁, 张彬彬, 施军平.《代谢相关(非酒精性)脂肪性肝病防治指南(2024年版)》解读[J]. 临床肝胆病杂志, 2024, 40( 9): 1767- 1770. DOI: 10.12449/JCH240908.
[49]	GHAFFARI M, SADEGHIYAN S, FARAMARZI M, et al. The effect of aerobic exercise on metabolic parameters of patients with non-alcoholic fatty liver disease: Systematic review and meta-analysis[J]. J Sports Med Phys Fitness, 2023, 63( 1): 178- 187. DOI: 10.23736/S0022-4707.22.13801-6.